This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ gemfibrozil,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Reduction of Triglycerides: Gemfibrozil is effective in lowering triglyceride levels in the blood. High triglyceride levels are associated with an increased risk of cardiovascular disease.

  2. Increase in HDL Cholesterol: Gemfibrozil can also raise high-density lipoprotein (HDL) cholesterol levels, often referred to as "good" cholesterol. HDL helps remove low-density lipoprotein (LDL) cholesterol from the arteries, reducing the risk of atherosclerosis and cardiovascular disease.

  3. Decrease in LDL Cholesterol: While gemfibrozil primarily targets triglycerides and HDL cholesterol, it may also modestly reduce low-density lipoprotein (LDL) cholesterol levels, commonly known as "bad" cholesterol.

  4. Cardiovascular Risk Reduction: By lowering triglycerides and increasing HDL cholesterol levels, gemfibrozil can help reduce the risk of cardiovascular events such as heart attacks and strokes, particularly in individuals with hypertriglyceridemia.

  5. Improvement in Lipid Profile: Gemfibrozil treatment often results in an overall improvement in lipid profile, characterized by lower triglyceride levels, higher HDL cholesterol levels, and sometimes modest reductions in LDL cholesterol.

  6. Prevention of Pancreatitis: High triglyceride levels are a risk factor for pancreatitis (inflammation of the pancreas). By lowering triglyceride levels, gemfibrozil may help reduce the risk of pancreatitis in susceptible individuals.

  7. Potential Side Effects: Common side effects of gemfibrozil include gastrointestinal symptoms such as abdominal pain, diarrhea, nausea, and indigestion. Some individuals may also experience muscle pain or weakness, which can be a sign of myopathy or rhabdomyolysis (muscle breakdown). These side effects are usually reversible upon discontinuation of the medication.

  8. Interactions with Other Medications: Gemfibrozil can interact with certain medications, including statins (cholesterol-lowering drugs), leading to an increased risk of myopathy or rhabdomyolysis. It is important to consult a healthcare professional before starting gemfibrozil if taking other medications.

  9. Liver Function Monitoring: Gemfibrozil may affect liver function, and periodic monitoring of liver enzymes may be necessary during treatment, particularly in individuals with pre-existing liver conditions.

  10. Contraindications: Gemfibrozil is contraindicated in individuals with severe liver or kidney disease, gallbladder disease, or a history of hypersensitivity to the medication.

  11. Long-Term Use: The long-term safety and efficacy of gemfibrozil have been established in numerous clinical trials. However, like any medication, it should be used with caution, and regular monitoring may be necessary, especially in individuals with multiple risk factors for cardiovascular disease.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of gemfibrozil,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Anaerobutyricum hallii Reduces
species Bacteroides uniformis Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium bifidum Reduces
species Bifidobacterium breve Reduces
species Bifidobacterium catenulatum Reduces
species Bifidobacterium longum Reduces
species Christensenella minuta Reduces
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces
species Parabacteroides distasonis Reduces
species Veillonella atypica Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by gemfibrozil,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

πŸ““ Direct Citations πŸ‘ͺπŸ‘Ά Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Bifidobacterium genus Decreases
0 1 Odoribacter genus Decreases
0 1 Clostridioides genus Decreases
0 1 Fusobacterium genus Decreases
0 1 Veillonella genus Decreases
0 1 Blautia genus Decreases
0 1 Roseburia genus Decreases
0 1 Bacteroides genus Decreases
0 1 Streptococcus genus Decreases
1 0 Akkermansia genus Decreases
0 1 Collinsella genus Decreases
0 1 Lacrimispora genus Decreases
0 1 Eggerthella genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Clostridium genus Decreases
0 1 Dorea genus Decreases
0 1 Enterocloster genus Decreases
0 1 Alistipes genus Decreases
0 1 Coprobacter genus Decreases
0 1 Lachnospira genus Decreases
0 1 Parabacteroides genus Decreases
0 1 Thomasclavelia genus Decreases
0 1 Escherichia genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Bacteroides caccae species Decreases
1 0 Fusobacterium nucleatum species Decreases
1 0 Bifidobacterium adolescentis species Decreases
1 0 Bifidobacterium longum species Decreases
1 0 Clostridioides difficile species Decreases
1 0 Odoribacter splanchnicus species Decreases
1 0 Veillonella parvula species Decreases
1 0 Blautia obeum species Decreases
1 0 Roseburia hominis species Decreases
1 0 Bacteroides ovatus species Decreases
1 0 Streptococcus parasanguinis species Decreases
1 0 Bacteroides uniformis species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Collinsella aerofaciens species Decreases
0 1 Streptococcus sp. HSISM1 species Decreases
0 1 Streptococcus sp. LPB0220 species Decreases
1 0 Lacrimispora saccharolytica species Decreases
0 1 Veillonella rodentium species Decreases
1 0 Eggerthella lenta species Decreases
1 0 [Ruminococcus] torques species Decreases
1 0 Clostridium perfringens species Decreases
1 0 Bacteroides fragilis species Decreases
1 0 Dorea formicigenerans species Decreases
1 0 Enterocloster bolteae species Decreases
0 1 Bifidobacterium breve species Decreases
0 1 Veillonella dispar species Decreases
0 1 Bifidobacterium angulatum species Decreases
1 0 Lachnospira eligens species Decreases
0 1 Veillonella sp. S12025-13 species Decreases
0 1 Bacteroides sp. D2 species Decreases
0 1 Bacteroides sp. DH3716P species Decreases
0 1 Veillonella nakazawae species Decreases
0 1 Bacteroides humanifaecis species Decreases
0 1 Bacteroides sp. M10 species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Veillonella rogosae species Decreases
0 1 Coprobacter secundus species Decreases
0 1 Butyricimonas faecalis species Decreases
0 1 Bacteroides sp. A1C1 species Decreases
0 1 Coprococcus catus species Decreases
0 1 Anaerobutyricum hallii species Decreases
0 1 Bacteroides sp. CACC 737 species Decreases
0 1 Alistipes megaguti species Decreases
0 1 Wansuia hejianensis species Decreases
0 1 Blautia sp. SC05B48 species Decreases
0 1 Streptococcus lactarius species Decreases
0 1 uncultured Alistipes sp. species Decreases
0 1 Dorea longicatena species Decreases
0 1 Butyricimonas virosa species Decreases
0 1 Bifidobacterium catenulatum species Decreases
0 1 Komagataeibacter oboediens species Decreases
0 1 Veillonella atypica species Decreases
0 1 Coprobacter fastidiosus species Decreases
0 1 Parolsenella catena species Decreases
0 1 Coprococcus comes species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Ligilactobacillus ruminis species Decreases
0 1 Butyrivibrio crossotus species Decreases
0 1 Eubacterium ventriosum species Decreases
0 1 Eubacterium sp. MSJ-33 species Decreases
0 1 Alistipes sp. dk3624 species Decreases
0 1 Blautia liquoris species Decreases
0 1 Alistipes onderdonkii species Decreases
0 1 Bifidobacterium bifidum species Decreases
0 1 Clostridium sp. M62/1 species Decreases
0 1 Qiania dongpingensis species Decreases
0 1 Streptococcus salivarius species Decreases
0 1 Alistipes ihumii species Decreases
0 1 Novisyntrophococcus fermenticellae species Decreases
0 1 Faecalitalea cylindroides species Decreases
0 1 Alistipes finegoldii species Decreases
0 1 Clostridium sp. SY8519 species Decreases
0 1 Alistipes senegalensis species Decreases
0 1 Ruminococcus albus species Decreases
0 1 Alistipes dispar species Decreases
0 1 Ruminococcus gauvreauii species Decreases
0 1 Streptococcus sp. FDAARGOS_192 species Decreases
0 1 Christensenella minuta species Decreases
0 1 Vescimonas fastidiosa species Decreases
0 1 Streptococcus australis species Decreases
0 1 Alistipes communis species Decreases
0 1 Alistipes shahii species Decreases
0 1 Massilistercora timonensis species Decreases
0 1 Maliibacterium massiliense species Decreases
0 1 Marvinbryantia formatexigens species Decreases
0 1 Parabacteroides merdae species Decreases
0 1 Faecalibacterium duncaniae species Decreases
0 1 Coprococcus eutactus species Decreases
0 1 Actinomyces naeslundii species Decreases
0 1 Wujia chipingensis species Decreases
0 1 Amedibacterium intestinale species Decreases
0 1 Anaerostipes hadrus species Decreases
0 1 Faecalibacillus intestinalis species Decreases
0 1 Lachnoclostridium phocaeense species Decreases
0 1 Streptococcus infantis species Decreases
0 1 Bacteroides nordii species Decreases
0 1 Leyella stercorea species Decreases
0 1 [Ruminococcus] lactaris species Decreases
0 1 [Clostridium] hylemonae species Decreases
0 1 Adlercreutzia equolifaciens species Decreases
0 1 Longicatena caecimuris species Decreases
0 1 Parolsenella massiliensis species Decreases
0 1 Vescimonas coprocola species Decreases
0 1 Intestinibaculum porci species Decreases
0 1 Barnesiella viscericola species Decreases
0 1 Clostridium cadaveris species Decreases
0 1 Catenibacterium mitsuokai species Decreases
0 1 Streptococcus sp. oral taxon 061 species Decreases
1 0 Parabacteroides distasonis species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
1 0 Thomasclavelia ramosa species Decreases
1 0 Escherichia coli species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases
0 1 Fusobacterium nucleatum subsp. nucleatum subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases

Impact of gemfibrozil,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.4 -0.4
ADHD 3.7 0.4 8.25
Age-Related Macular Degeneration and Glaucoma 0.5 0 0
Allergic Rhinitis (Hay Fever) 1.5 2.6 -0.73
Allergies 4.7 2.3 1.04
Allergy to milk products 0.9 0.8 0.13
Alopecia (Hair Loss) 0.6 0.6
Alzheimer's disease 4.7 4 0.18
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.9 0.4 3.75
Ankylosing spondylitis 2.2 0.6 2.67
Anorexia Nervosa 1.1 1.7 -0.55
Antiphospholipid syndrome (APS) 0.2 0.2
Asthma 3.8 2.5 0.52
Atherosclerosis 1.4 1.2 0.17
Atrial fibrillation 1.9 0.8 1.37
Autism 5.5 5.2 0.06
Autoimmune Disease 0.6 0.8 -0.33
Barrett esophagus cancer 0.6 0.2 2
benign prostatic hyperplasia 0 0.2 0
Biofilm 1.6 1.6
Bipolar Disorder 0.6 0.6 0
Brain Trauma 0.9 0.9 0
Breast Cancer 0.7 0.7
Cancer (General) 0.9 2.4 -1.67
Carcinoma 3 1.7 0.76
Celiac Disease 1.9 2.6 -0.37
Cerebral Palsy 1.4 0.7 1
Chronic Fatigue Syndrome 3.4 3.4 0
Chronic Kidney Disease 2.6 1.2 1.17
Chronic Lyme 0.6 0.5 0.2
Chronic Obstructive Pulmonary Disease (COPD) 1.3 1.1 0.18
Chronic Urticaria (Hives) 0.7 0.6 0.17
Coagulation / Micro clot triggering bacteria 0.3 0.7 -1.33
Cognitive Function 1.1 1.4 -0.27
Colorectal Cancer 4.1 1.3 2.15
Constipation 0.3 0.5 -0.67
Coronary artery disease 0.6 1.8 -2
COVID-19 7.1 7.4 -0.04
Crohn's Disease 4.5 3.5 0.29
Cushing's Syndrome (hypercortisolism) 0.2 -0.2
cystic fibrosis 0.1 1.7 -16
d-lactic acidosis (one form of brain fog) 0 0
deep vein thrombosis 1.1 0.7 0.57
Denture Wearers Oral Shifts 1.5 1.5
Depression 6.8 5.2 0.31
Dermatomyositis 0.2 0.4 -1
Eczema 0.9 1.6 -0.78
Endometriosis 1.3 1 0.3
Eosinophilic Esophagitis 0.3 0.5 -0.67
Epilepsy 2.6 1.6 0.63
erectile dysfunction 0.7 0.5 0.4
Fibromyalgia 1.7 1.2 0.42
Functional constipation / chronic idiopathic constipation 2.9 2.6 0.12
gallstone disease (gsd) 1.1 1.2 -0.09
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.4 1.3 0.08
Generalized anxiety disorder 1.4 1.7 -0.21
giant cell arteritis 0.1 -0.1
Glioblastoma 0.2 -0.2
Gout 1.2 0.3 3
Graves' disease 1.1 2.1 -0.91
Gulf War Syndrome 0.6 1.2 -1
Halitosis 1.6 0.2 7
Hashimoto's thyroiditis 2.7 1.1 1.45
Heart Failure 2.1 1.2 0.75
hemorrhagic stroke 0.6 0.6
Hidradenitis Suppurativa 0.8 0.3 1.67
High Histamine/low DAO 0.7 0.4 0.75
hypercholesterolemia (High Cholesterol) 0.5 0.4 0.25
hyperglycemia 0.8 1.5 -0.88
Hyperlipidemia (High Blood Fats) 0.8 0.3 1.67
hypersomnia 0.4 -0.4
hypertension (High Blood Pressure 2.5 4.3 -0.72
Hypothyroidism 0.2 0.8 -3
Hypoxia 1.3 1.3
IgA nephropathy (IgAN) 0.9 3 -2.33
Inflammatory Bowel Disease 5.7 6 -0.05
Insomnia 1.3 1.9 -0.46
Intelligence 1 1
Intracranial aneurysms 0.8 0.2 3
Irritable Bowel Syndrome 5.1 3.4 0.5
ischemic stroke 2.1 0.5 3.2
Liver Cirrhosis 4.4 2.8 0.57
Long COVID 4.2 5.1 -0.21
Low bone mineral density 0.7 -0.7
Lung Cancer 0.7 1 -0.43
Lymphoma 0 0.2 0
Mast Cell Issues / mastitis 0.8 0.5 0.6
ME/CFS with IBS 0.6 1.9 -2.17
ME/CFS without IBS 0.8 1.2 -0.5
membranous nephropathy 0.2 0.2
Menopause 2.2 0.5 3.4
Metabolic Syndrome 4.4 6 -0.36
Mood Disorders 7.9 4.2 0.88
multiple chemical sensitivity [MCS] 0.8 0.3 1.67
Multiple Sclerosis 4.3 2.7 0.59
Multiple system atrophy (MSA) 1.5 0.7 1.14
myasthenia gravis 0.2 0.4 -1
neuropathic pain 0.1 2.2 -21
Neuropathy (all types) 0.8 0.9 -0.13
neuropsychiatric disorders (PANDAS, PANS) 0.6 0.6
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 3 4.2 -0.4
NonCeliac Gluten Sensitivity 1.5 0.6 1.5
Obesity 6.7 5.6 0.2
obsessive-compulsive disorder 3.5 2.2 0.59
Osteoarthritis 1.6 1.1 0.45
Osteoporosis 1 1.5 -0.5
pancreatic cancer 1.2 0.2 5
Parkinson's Disease 5.4 3.3 0.64
Peanut Allergy 0.1 -0.1
Polycystic ovary syndrome 2.9 2.1 0.38
Postural orthostatic tachycardia syndrome 0.1 0.5 -4
Premenstrual dysphoric disorder 0.8 0 0
primary biliary cholangitis 0.6 1.2 -1
Primary sclerosing cholangitis 2.3 1.3 0.77
Psoriasis 2.3 1.1 1.09
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 3.9 2.8 0.39
Rosacea 0.6 0.4 0.5
Schizophrenia 5.4 1.8 2
scoliosis 0.2 0.2 0
sensorineural hearing loss 0.1 0.1
Sjögren syndrome 1.9 2.1 -0.11
Sleep Apnea 1.1 1 0.1
Slow gastric motility / Gastroparesis 0.5 0.4 0.25
Small Intestinal Bacterial Overgrowth (SIBO) 1.2 0.6 1
Stress / posttraumatic stress disorder 1.7 1.7 0
Systemic Lupus Erythematosus 2.2 1.8 0.22
Tic Disorder 0.6 1 -0.67
Tourette syndrome 0.5 0.2 1.5
Type 1 Diabetes 2.3 2.9 -0.26
Type 2 Diabetes 4.6 4.3 0.07
Ulcerative colitis 3.1 4.6 -0.48
Unhealthy Ageing 3.1 1.5 1.07
Vitiligo 1.2 1 0.2

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]